Skip to main content
. 2020 Dec 15;9(12):e21772. doi: 10.2196/21772

Table 2.

Overview of cessation assistance characteristics included in the decision aid (DA).

Cessation assistance characteristic Rationale for inclusion in the DA This characteristic is included in the statements (VCMa) for:
Effectiveness of the cessation assistance options

During the interviews with potential end users, this was both the most mentioned characteristic and considered the most important characteristic. Behavioral support, prescription medication
Probability of nausea and dizziness when the cessation assistance option is used

Probability of side effects was the third most often mentioned characteristic during the interviews with potential end users and was also considered to be of importance by the clinicians. The first 3 side effects were specifically named as important by potential end users, while the fourth was added, as this is a common side effect. Other side effects were included if they are regarded as being very likely to occur.

Nicotine replacement therapy, prescription medication
Probability of mood changes when the cessation assistance option is used

Probability of headaches when the cessation assistance option is used
Probability of sleeping problems when the cessation assistance option is used
Probability of other side effects that are very likely to occur when the cessation assistance option is used
Extent and type of contact someone has with a professional when the cessation assistance option is used

Both scientists and potential end users indicated that this was of great importance. Clinicians indicated that required contact with a health care professional was of great importance. Behavioral support
How the cessation assistance option is used This was integrated after it had been decided that Dutch health insurance companies would cover evidence-based cessation assistance use, as that left too few features to distinguish between the different nicotine replacement therapies and prescription medication. Nicotine replacement therapy, prescription medication

aVCM: value clarification method.